Skip to search formSkip to main contentSkip to account menu

Exelon

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
β-secretase is regarded as one of the best characterized targets for Alzheimer's disease therapy. β-secretase 1 protease plays an… 
2009
2009
Peculiarities of the model of medical-psychological help elaborated by the authors are presented on the example of the… 
Review
2009
Review
2009
The use of rivastigmine in the rehabilitation of patients with cognitive disturbances after cranial-brain trauma (CBT) is… 
Review
2009
Review
2009
The use of rivastigmine in the rehabilitation of patients with cognitive disturbances after cranial-brain trauma (CBT) is… 
2008
2008
The action of Ebixa is quite different to, and more complex than, that of Aricept, Exelon and Reminyl. Ebixa blocks a messenger… 
2008
2008
To study efficacy and safety of cholinergic therapy in patients with Alzheimer's disease or combined Alzheimer's and vascular… 
2006
2006
  • S. Gavrilova
  • 2006
  • Corpus ID: 21575343
The role of apolipoprotein E (ApoE) genotype in the forming of response to various kinds of pathogenetic therapy of Alzheimer's… 
2005
2005
Correlation association between an ApoE4 genotype in patients with mild-moderate Alzheimer's disease and efficacy of neurotrophic… 
Review
2005
Review
2005
BACKGROUND Vascular dementia represents the second most common type of dementia. The classification of vascular dementia broadly…